Spinal-Fluid Test Is Found to Predict Alzheimer’s
(Source:Archives of Neurology)
A recent research study found that a spinal fluid test can be 100 percent accurate in identifying patients with significant memory loss who are on their way to developing Alzheimer’s disease.The new study included more than 300 patients in their 70s whose spinal fluid was analyzed for amyloid beta, a protein fragment that forms plaques in the brain, and for tau, a protein that accumulates in dead and dying nerve cells in the brain.
The results showed that nearly every person with Alzheimer’s had the characteristic spinal fluid protein levels. Nearly three quarters of people with mild cognitive impairment, a memory impediment that can precede Alzheimer’s, had Alzheimer’s-like spinal fluid proteins. And every one of those patients with the proteins developed Alzheimer’s within five years. And about a third of people with normal memories had spinal fluid indicating Alzheimer’s. Researchers suspect that those people will develop memory problems.
Name that tune: Alzheimer's patients more easily recall new information when it is sung to them
(Source:Journal Neuropsychologia) Researchers at the Boston University School of Medicine set out to determine whether Alzheimer's patients would be better able to recall new information if it was sung to them, as opposed to merely spoken. Alzheimer's patients and older healthy control subjects were visually presented with the lyrics to 40 songs. Half of the lyrics were presented along with the original recordings. The other half was presented in a spoken format. They found that the Alzheimer's patients could more easily recall the lyrics when they were accompanied by the musical recording.
Israel tests new Alzheimer's treatment
(Source:Israel21c.org)Israel-based Avraham Pharmaceuticals has received a $9 million investment to pursue a Phase IIb clinical trial of Ladostigil, a novel drug for the treatment of Alzheimer's disease. Ladostigil was envisaged by Prof. Marta Weinstock-Rosin (wife of Prof. Rosin from Melabev) of the Department of Pharmacology, School of Pharmacy at the Hebrew University of Jerusalem and Prof. Moussa B.H. Youdim of the Eve Top and National Parkinson Foundation Centers of Excellence Rappaport School of Medicine, Technion, Haifa, Israel
New Alzheimer's Drug May Reverse Dementia Symptoms
(Source: Medicalnewstoday.com)Prana Biotechnology announced findings that the company's experimental drug, PBT2, may be able to reverse dementia symptoms.
Combination of Depression and Diabetes Doubles the risk for Dementia
(Source: University of Washington) - According to a recent study, adults who have both diabetes and major depression are more than twice as likely to develop dementia, compared to adults with diabetes only.
Atitudes of families to the use of GPS-tracking devices
(Source:Social Science research network)This study examined the attitudes of family and professional care-givers towards the use of advanced electronic tracking such as GPS (Global Positioning Systems) and RFID (Radio Frequency Identification) for elderly people with dementia.
Use of Psychotropics in Nursing Homes Dangerous for Dementia Patients
(Source: Boston Globe)
Greek study shows Memantine has positive effects on Alzheimer's Patients
(Source: Docguide) Cognitive and neuropsychiatric symptoms improved or remained the same in 80% of 1,469 Alzheimer's patients after 6 months of treatment with memantine.